SCHEMBL1002894

SCHEMBL1002894

C=CCOCC=C.CCC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
KMT2A Q03164 1/20 0.43
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CA9 Q16790 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CA7 P43166 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL4624716 0.93 MEN1 (0.39) TSHRTDP1MEN1POLBKMT2A
Acrylic Acid SCHEMBL4623017 0.85 LMNA (0.40) TSHRTDP1MEN1POLBKMT2A
SCHEMBL27416000 0.84 MEN1 (0.40) TSHRMEN1POLBKMT2ACA1
Propane SCHEMBL892321 0.82 MEN1 (0.50) TSHRTDP1MEN1POLBKMT2A
Chloromethane SCHEMBL15265334 0.82
Charcoal, Activated SCHEMBL206515 0.82
SCHEMBL28757746 0.81 MEN1 (0.41) TSHRMEN1POLBKMT2ACA1
Butane SCHEMBL27399074 0.79 MEN1 (0.48) TSHRMEN1POLBKMT2ACA1
Ethane SCHEMBL27452377 0.78
SCHEMBL15068452 0.78 CA1 (0.46) TSHRMEN1POLBKMT2ACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200324018-A1 ENDOLUMINAL DEVICE AND POLYMER SILICON VALLEY BANK 2020-10-15 US claimed
EP-3700465-A1 ENDOLUMINAL DEVICE AND POLYMER Endologix, Inc. (US) 2020-09-02 EP claimed
CN-111278386-A Endoluminal device and polymer 恩朵罗杰克斯股份有限公司 2020-06-12 CN claimed
US-10039864-B2 Oligofluorinated cross-linked polymers and uses thereof INTERFACE BIOLOGICS, INC. (CA) 2018-08-07 US claimed
US-20170340781-A1 OLIGOFLUORINATED CROSS-LINKED POLYMERS AND USES THEREOF Evonik Canada Inc. (CA) 2017-11-30 US claimed
US-20110091508-A1 OLIGOFLUORINATED CROSS-LINKED POLYMERS AND USES THEREOF Interface Biologics ,Inc. (CA) 2011-04-21 US claimed
JP-2011502182-A 2011-01-20 JP claimed
EP-2203498-A1 OLIGOFLUORINATED CROSS-LINKED POLYMERS AND USES THEREOF Interface Biologics Inc. (CA) 2010-07-07 EP claimed
EP-2142578-A1 THERMOSETTING RESIN COMPOSITION Scott Bader Company Limited (GB) 2010-01-13 EP claimed
WO-2009043174-A1 OLIGOFLUORINATED CROSS-LINKED POLYMERS AND USES THEREOF INTERFACE BIOLOGICS INC. (CA) 2009-04-09 WO claimed
WO-2008119973-A1 THERMOSETTING RESIN COMPOSITION SCOTT BADER COMPANY LIMITED (GB) 2008-10-09 WO claimed
CN-118027301-A Silicon-based acrylic ester modified waterborne polyurethane emulsion and preparation method thereof 陕西科技大学 2024-05-14 CN disclosed
CN-117987004-A Ultraviolet-cured organic silicon hydrophobic coating and preparation method and application thereof 浙江赢科新材料股份有限公司 2024-05-07 CN disclosed
US-11532817-B2 Binder composition for nonaqueous secondary batteries and slurry composition for nonaqueous secondary batteries ZEON CORPORATION (JP) 2022-12-20 US disclosed
CN-111065667-B Multi-component dispersants 毕克化学有限公司 2022-03-04 CN disclosed
US-5472823-A Polyamic acids HITACHI CHEMICAL CO., LTD. (JP) 1995-12-05 US disclosed
CN-1107161-A Carboxyl group-containing emulsifiers for aqueous vinyl halide polymerization HUNG S PARK (US) 1995-08-23 CN disclosed
CN-1072602-A Improve the enhanced dermal osmosis system of the local conveying of medicine RICHARDSON VICKS INC (US) 1993-06-02 CN disclosed
US-4925893-A WATERBASED AUTOOXIDIZABLE COATING, CONTAINS GEL FRACTION IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-05-15 US disclosed
EP-0297781-A2 Curable coating compositions and their preparation and use IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110091508-A1 OLIGOFLUORINATED CROSS-LINKED POLYMERS AND USES THEREOF MACF1, PUF60, PFAS TSHR 4009/4885TDP1 2166/4885MEN1 4831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.